Po materialam klinicheskikh rekomendatsiy po diagnostike sindroma Kushinga

Cover Page

Abstract


Полный текст: The diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline. Авторы: L.K. Nieman, B.M.K. Biller, J. W. Findling, J.Newell-Price, M.O. Savage, P.M. Stewart, and V.M. Montori Journal of Clinical Endocrinology & Metabolism, May 2008, 93(5): 1526-1540

D G Bel'tsevich

  1. L.K. Nieman, B.M.K. Biller, J. W. Findling, J.Newell-Price, M.O. Savage, P.M. Stewart, and V.M. Montori. The diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, May 2008, 93(5): 1526-1540
  2. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y,Flottorp S, Guyatt GH, Harbour RT, Haugh MC, HenryD, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D,Oxman AD, Phillips B, Schunemann HJ, Edejer TT,Varonen H, Vist GE, Williams Jr JW, Zaza S 2004 Grading quality of evidence and strength ofrecommendations. BMJ 328:1490
  3. Elamin MB, Murad MH, Mullan R, Erickson D, HarrisK, Nadeem S, Ennis R, Erwin PJ, Montori VM 2008 Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses. J Clin Endocrinol Metab 93:1553-1562
  4. Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, GUyatt GH, Montori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the GRADE system. J Clin Endocrinol Metab 93:666-673
  5. Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484
  6. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J 2001 Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123
  7. Nugent CA, Warner HR, Dunn JT, Tyler FH 1964 Probability theory in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 24:621-627
  8. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F 2007 The dexamethasonesup ressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66:251-257
  9. Ross EJ, Linch DC 1982 Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646-649
  10. Yanovski JA, Cutler GB, Jr., Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudoCushing’s states. JAMA 269:2232-2238
  11. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, et al. 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. Pathophysiologic and diagnostic implications. N Engl J Med 314:1329-1335
  12. Cushing H 1932 The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137-195
  13. Plotz CM, Knowlton AI, Ragan C 1952 The natural history of Cushing’s syndrome. Am J Med 13:597-614
  14. Swearingen B, Biller BM, Barker 2nd FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT 1999 Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 130:821-824
  15. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
  16. Wei L, MacDonald TM, Walker BR 2004 Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770
  17. Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L, Lacroix A 2002 Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87:1949-1954
  18. Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing’s syndrome. J Clin Endocrinol Metab 80:2859-2865
  19. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK 2006 Long-term impaired quality of life in Cushing’s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447-453
  20. Sarlis NJ, Chanock SJ, Nieman LK 2000 Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 85:42-47
  21. Reincke M 2000 Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am 29:43-56
  22. Terzolo M, Reimondo G, Bovio S, Angeli A 2004 Subclinical Cushing’s syndrome. Pituitary 7:217-223
  23. Tsagarakis S, Vassiliadi D, Thalassinos N 2006 Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest 29:471-482
  24. Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH, 3rd, Nwariaku FE 2007 “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900-905
  25. Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO 2005 Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol (Oxf) 62:466-472
  26. Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO 2004 Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 61:553-559
  27. Magiakou MA, Mastorakos G, Chrousos GP 1994 Final stature in patients with endogenous Cushing’s syndrome. J Clin Endocrinol Metab 79:1082-1085
  28. Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA 2005 Iatrogenic Cushing’s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 90:4394-4398
  29. Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK 2007 Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102-3107
  30. Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M 1997 Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 157:1651-1656
  31. Batista DL, Riar J, Keil M, Stratakis CA 2007 Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 120:e575-e586
  32. Bulow B, Jansson S, Juhlin C, Steen L, Thoren M, Wahrenberg H, Valdemarsson S, Wangberg B, Ahren B 2006 Adrenal incidentaloma—follow-up results from a Swedish prospective study. Eur J Endocrinol 154:419-423
  33. Libe R, Dall’Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147:489-494
  34. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A 2003 Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808-5813
  35. Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M 2007 Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67:225-229
  36. Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L 2002 Overnight dexamethasone suppression test: a reliable screen for Cushing’s syndrome in the obese. Obes Res 10:1217-1221
  37. Anderson Jr GH, Blakeman N, Streeten DH 1994 The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12:609-615
  38. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193-202
  39. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A 2007 Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147:541-548
  40. Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, Andersen M, Feldt-Rasmussen U 2007 Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab 92:1326-1333
  41. Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC 1998 Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. Endocrinologist 8:51-54
  42. Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH 2003 Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab 88:3521-3524
  43. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC 1997 Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:151-155
  44. Turpeinen U, Markkanen H, Valimaki M, Stenman UH 1997 Determination of urinary free cortisol by HPLC. Clin Chem 43:1386-1391
  45. Nickelsen T, Lissner W, Schoffling K 1989 The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol 94:275-280
  46. Qureshi AC, Bahri A, Breen LA, Barnes SC, Powrie JK, Thomas SM, Carroll PV 2007 The influence of the route of oestrogen administration on serum levels of cortisolbinding globulin and total cortisol. Clin Endocrinol (Oxf) 66:632-635

Views

Abstract - 750

PDF (Russian) - 627

Cited-By


Dimensions


Copyright (c) 2009 .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies